Add Company
Join Now

Elixirgen Therapeutics Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Elixirgen Therapeutics's estimated annual revenue is currently $2.5M per year.(i)
  • Elixirgen Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • Elixirgen Therapeutics has 16 Employees.(i)
  • Elixirgen Therapeutics grew their employee count by 0% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.3M2-60%N/AN/A
#2
$2.9M38-31%$17.5MN/A
#3
$2.9M38-33%$10.5MN/A
#4
$19.8M1280%$69.4MN/A
#5
$9.6M62-15%N/AN/A
#6
$1.4M90%N/AN/A
#7
$2.5M160%N/AN/A
#8
$7.4M480%N/AN/A
#9
$0.2M1-83%N/AN/A
#10
$1.7M1122%N/AN/A
Add Company

What Is Elixirgen Therapeutics?

Elixirgen Therapeutics is a biotechnology company focused on curing humanity’s ailments through stem cell biology. Founded in 2017 by Minoru S.H. Ko, M.D., Ph.D., a renowned specialist in stem cell biology, the company concentrates on regenerative and rejuvenative medicine, and deals with research in both basic science and in the application of the technologies it discovers and refines. Elixirgen Therapeutics is located in the Science + Technology Park at Johns Hopkins in Baltimore, an ideal research environment that allows Elixirgen Therapeutics’ scientists to conduct research at state-of-the-art facilities. Elixirgen Therapeutics inherits all the therapy-related assets, including intellectual property, from its parent company, Elixirgen, LLC, which has been in active operation since the beginning of 2012.

keywords:N/A

N/A

Total Funding

16

Number of Employees

$2.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.2M16-6%$34.7M
#2
$2.4M16-11%N/A
#3
$4M167%N/A
#4
$4M167%N/A
#5
$1.4M167%N/A